Research Article - (2016) Volume 7, Issue 4
Development of inCVAX, In situ Cancer Vaccine, and Its Immune Response in Mice with Hepatocellular Cancer
- Xiaoqiang Qi1,2, Samuel SK Lam3, Dai Liu1,2, Dae Young Kim4, Lixin Ma5, Lu Alleruzzo3, Wei Chen6, Tomas Hode3, Carolyn J Henry7, Jussuf Kaifi1,2, Eric T Kimchi1,2, Guangfu Li1,2* and Kevin F Staveley-O’Carroll1,2,7*
- 1Department of Surgery, University of Missouri, Columbia, MO 65212, USA
- 2Ellis Fischel Cancer Center, University of Missouri, Columbia, MO 65212, USA
- 3Immunophotonics Inc., 4320 Forest Park Avenue #303, St. Louis, Missouri 63108, USA
- 4Veterinary Medical Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, Columbia, MO 65212, USA
- 5Department of Radiology, University of Missouri, Columbia, MO 65212; Harry S. Truman Memorial VA Hospital Biomolecular Imaging Center, USA
- 6Veterinary Medical and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65212, USA
- 7Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65212, USA
*Corresponding Author(s):
Guangfu Li,
Ph.D., DVM., Assistant Professor, Department of Surgery, Ellis Fischel Cancer Center, University of Missouri, One Hospital Drive, Columbia, MO 65212, USA, Tel: 573-882-8454, Fax: 573-884-6054
Email:
Kevin F Staveley-O’Carroll,
M.D., Ph.D., Professor and Chair of Surgery, Director of Ellis Fischel Cancer Center, University of Missouri, One Hospital Drive, Columbia, MO 65212, USA, Tel: 573-882-8454, Fax: 573-884-6054
Email:
